> top > docs > PMC:7597510 > spans > 1014-12571 > annotations

PMC:7597510 / 1014-12571 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid_Glycan-Motif-Structure

Id Subject Object Predicate Lexical cue
T1 884-887 https://glytoucan.org/Structures/Glycans/G46613JI denotes GM1
T2 884-887 https://glytoucan.org/Structures/Glycans/G48558GR denotes GM1
T3 894-898 https://glytoucan.org/Structures/Glycans/G17077FL denotes GQ1b
T4 894-898 https://glytoucan.org/Structures/Glycans/G18625KA denotes GQ1b
T5 908-912 https://glytoucan.org/Structures/Glycans/G37184KW denotes GD1b
T6 908-912 https://glytoucan.org/Structures/Glycans/G97612UN denotes GD1b
T7 3448-3455 https://glytoucan.org/Structures/Glycans/G15021LG denotes glucose
T8 3792-3795 https://glytoucan.org/Structures/Glycans/G46613JI denotes GM1
T9 3792-3795 https://glytoucan.org/Structures/Glycans/G48558GR denotes GM1
T10 3797-3800 https://glytoucan.org/Structures/Glycans/G61168WC denotes GM2
T11 3797-3800 https://glytoucan.org/Structures/Glycans/G79389NT denotes GM2
T12 3802-3806 https://glytoucan.org/Structures/Glycans/G46677TE denotes GD1a
T13 3802-3806 https://glytoucan.org/Structures/Glycans/G69277LC denotes GD1a
T14 3808-3812 https://glytoucan.org/Structures/Glycans/G37184KW denotes GD1b
T15 3808-3812 https://glytoucan.org/Structures/Glycans/G97612UN denotes GD1b
T16 3814-3817 https://glytoucan.org/Structures/Glycans/G81928IQ denotes GD3
T17 3814-3817 https://glytoucan.org/Structures/Glycans/G98544DH denotes GD3
T18 3819-3830 https://glytoucan.org/Structures/Glycans/G92175CL denotes GalNAc-GD1a
T19 3832-3836 https://glytoucan.org/Structures/Glycans/G68110IF denotes GT1a
T20 3832-3836 https://glytoucan.org/Structures/Glycans/G93468NI denotes GT1a
T21 3838-3842 https://glytoucan.org/Structures/Glycans/G05952XV denotes GT1b
T22 3838-3842 https://glytoucan.org/Structures/Glycans/G40183QN denotes GT1b
T23 3844-3848 https://glytoucan.org/Structures/Glycans/G17077FL denotes GQ1b
T24 3844-3848 https://glytoucan.org/Structures/Glycans/G18625KA denotes GQ1b
T25 3858-3868 https://glytoucan.org/Structures/Glycans/G00407UJ denotes asialo-GM1
T26 3858-3868 https://glytoucan.org/Structures/Glycans/G21856LC denotes asialo-GM1
T27 8363-8366 https://glytoucan.org/Structures/Glycans/G46613JI denotes GM1
T28 8363-8366 https://glytoucan.org/Structures/Glycans/G48558GR denotes GM1
T29 8373-8377 https://glytoucan.org/Structures/Glycans/G17077FL denotes GQ1b
T30 8373-8377 https://glytoucan.org/Structures/Glycans/G18625KA denotes GQ1b
T31 8387-8391 https://glytoucan.org/Structures/Glycans/G37184KW denotes GD1b
T32 8387-8391 https://glytoucan.org/Structures/Glycans/G97612UN denotes GD1b

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T4 247-258 Body_part denotes glycolipids http://purl.org/sig/ont/fma/fma82780
T5 267-278 Body_part denotes ganglioside http://purl.org/sig/ont/fma/fma82816
T6 788-796 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T7 1923-1934 Body_part denotes extremities http://purl.org/sig/ont/fma/fma7182
T8 2147-2152 Body_part denotes chest http://purl.org/sig/ont/fma/fma9576
T9 2601-2618 Body_part denotes lower extremities http://purl.org/sig/ont/fma/fma7184
T10 2649-2666 Body_part denotes upper extremities http://purl.org/sig/ont/fma/fma7183
T11 2727-2738 Body_part denotes extremities http://purl.org/sig/ont/fma/fma7182
T12 2821-2843 Body_part denotes central nervous system http://purl.org/sig/ont/fma/fma55675
T13 2845-2851 Body_part denotes Tendon http://purl.org/sig/ont/fma/fma9721
T14 2868-2885 Body_part denotes upper extremities http://purl.org/sig/ont/fma/fma7183
T15 2932-2949 Body_part denotes lower extremities http://purl.org/sig/ont/fma/fma7184
T16 2996-3002 Body_part denotes muscle http://purl.org/sig/ont/fma/fma32558
T17 3052-3059 Body_part denotes muscles http://purl.org/sig/ont/fma/fma32558
T18 3067-3084 Body_part denotes lower extremities http://purl.org/sig/ont/fma/fma7184
T19 3126-3133 Body_part denotes muscles http://purl.org/sig/ont/fma/fma32558
T20 3141-3158 Body_part denotes upper extremities http://purl.org/sig/ont/fma/fma7183
T21 3336-3347 Body_part denotes extremities http://purl.org/sig/ont/fma/fma7182
T22 3414-3419 Body_part denotes Blood http://purl.org/sig/ont/fma/fma9670
T23 3442-3447 Body_part denotes blood http://purl.org/sig/ont/fma/fma9670
T24 3448-3455 Body_part denotes glucose http://purl.org/sig/ont/fma/fma82743
T25 3493-3501 Body_part denotes collagen http://purl.org/sig/ont/fma/fma63891
T26 3511-3518 Body_part denotes thyroid http://purl.org/sig/ont/fma/fma9603
T27 3553-3572 Body_part denotes Cerebrospinal fluid http://purl.org/sig/ont/fma/fma20935
T28 3574-3577 Body_part denotes CSF http://purl.org/sig/ont/fma/fma20935
T29 3656-3663 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T30 3675-3679 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T31 3748-3759 Body_part denotes ganglioside http://purl.org/sig/ont/fma/fma82816
T32 3871-3882 Body_part denotes Ganglioside http://purl.org/sig/ont/fma/fma82816
T33 3984-3987 Body_part denotes CSF http://purl.org/sig/ont/fma/fma20935
T34 4188-4194 Body_part denotes muscle http://purl.org/sig/ont/fma/fma32558
T35 4256-4269 Body_part denotes tibial nerves http://purl.org/sig/ont/fma/fma19035
T36 4441-4446 Body_part denotes Nerve http://purl.org/sig/ont/fma/fma65132
T37 4470-4475 Body_part denotes nerve http://purl.org/sig/ont/fma/fma65132
T38 4493-4498 Body_part denotes Nerve http://purl.org/sig/ont/fma/fma65132
T39 4762-4767 Body_part denotes Wrist http://purl.org/sig/ont/fma/fma24922
T40 4867-4872 Body_part denotes Elbow http://purl.org/sig/ont/fma/fma24901
T41 4873-4878 Body_part denotes wrist http://purl.org/sig/ont/fma/fma24922
T42 4910-4915 Body_part denotes Wrist http://purl.org/sig/ont/fma/fma24922
T43 5016-5021 Body_part denotes Elbow http://purl.org/sig/ont/fma/fma24901
T44 5022-5027 Body_part denotes wrist http://purl.org/sig/ont/fma/fma24922
T45 5061-5066 Body_part denotes Wrist http://purl.org/sig/ont/fma/fma24922
T46 5142-5147 Body_part denotes Elbow http://purl.org/sig/ont/fma/fma24901
T47 5148-5153 Body_part denotes wrist http://purl.org/sig/ont/fma/fma24922
T48 5297-5301 Body_part denotes Knee http://purl.org/sig/ont/fma/fma24974
T49 5349-5354 Body_part denotes Ankle http://purl.org/sig/ont/fma/fma9665
T50 5435-5441 Body_part denotes fibula http://purl.org/sig/ont/fma/fma24479
T51 5442-5447 Body_part denotes ankle http://purl.org/sig/ont/fma/fma9665
T52 5477-5482 Body_part denotes nerve http://purl.org/sig/ont/fma/fma65132
T53 5500-5505 Body_part denotes Nerve http://purl.org/sig/ont/fma/fma65132
T54 5697-5702 Body_part denotes Wrist http://purl.org/sig/ont/fma/fma24922
T55 5773-5778 Body_part denotes Elbow http://purl.org/sig/ont/fma/fma24901
T56 5779-5784 Body_part denotes wrist http://purl.org/sig/ont/fma/fma24922
T57 5840-5845 Body_part denotes Wrist http://purl.org/sig/ont/fma/fma24922
T58 5920-5925 Body_part denotes Elbow http://purl.org/sig/ont/fma/fma24901
T59 5926-5931 Body_part denotes wrist http://purl.org/sig/ont/fma/fma24922
T60 5985-5990 Body_part denotes Wrist http://purl.org/sig/ont/fma/fma24922
T61 6064-6069 Body_part denotes Elbow http://purl.org/sig/ont/fma/fma24901
T62 6070-6075 Body_part denotes wrist http://purl.org/sig/ont/fma/fma24922
T63 6176-6181 Body_part denotes Ankle http://purl.org/sig/ont/fma/fma9665
T64 6259-6281 Body_part denotes abductor digiti minimi http://purl.org/sig/ont/fma/fma37451
T65 6288-6312 Body_part denotes abductor pollicis brevis http://purl.org/sig/ont/fma/fma37373
T66 6366-6391 Body_part denotes extensor digitorum brevis http://purl.org/sig/ont/fma/fma51140
T67 6398-6414 Body_part denotes extensor indicis http://purl.org/sig/ont/fma/fma38524
T68 6430-6452 Body_part denotes flexor hallucis brevis http://purl.org/sig/ont/fma/fma37449
T69 7059-7073 Body_part denotes immunoglobulin http://purl.org/sig/ont/fma/fma62871
T70 7268-7283 Body_part denotes Achilles tendon http://purl.org/sig/ont/fma/fma51061
T71 7957-7968 Body_part denotes ganglioside http://purl.org/sig/ont/fma/fma82816
T72 8157-8168 Body_part denotes ganglioside http://purl.org/sig/ont/fma/fma82816
T73 9128-9139 Body_part denotes endothelium http://purl.org/sig/ont/fma/fma63916
T74 9286-9296 Body_part denotes macrophage http://purl.org/sig/ont/fma/fma63261
T75 9323-9331 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T76 9722-9737 Body_part denotes lower extremity http://purl.org/sig/ont/fma/fma7184
T77 9823-9834 Body_part denotes lower limbs http://purl.org/sig/ont/fma/fma7184
T78 9857-9872 Body_part denotes lower extremity http://purl.org/sig/ont/fma/fma7184
T79 10186-10189 Body_part denotes CSF http://purl.org/sig/ont/fma/fma20935

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T2 2147-2152 Body_part denotes chest http://purl.obolibrary.org/obo/UBERON_0001443
T3 2821-2843 Body_part denotes central nervous system http://purl.obolibrary.org/obo/UBERON_0001017
T4 2829-2843 Body_part denotes nervous system http://purl.obolibrary.org/obo/UBERON_0001016
T5 2845-2851 Body_part denotes Tendon http://purl.obolibrary.org/obo/UBERON_0000043
T6 2980-2985 Body_part denotes Scale http://purl.obolibrary.org/obo/UBERON_0002542
T7 3414-3419 Body_part denotes Blood http://purl.obolibrary.org/obo/UBERON_0000178
T8 3442-3447 Body_part denotes blood http://purl.obolibrary.org/obo/UBERON_0000178
T9 3511-3518 Body_part denotes thyroid http://purl.obolibrary.org/obo/UBERON_0002046
T10 3553-3572 Body_part denotes Cerebrospinal fluid http://purl.obolibrary.org/obo/UBERON_0001359
T11 4256-4269 Body_part denotes tibial nerves http://purl.obolibrary.org/obo/UBERON_0001323
T12 4441-4446 Body_part denotes Nerve http://purl.obolibrary.org/obo/UBERON_0001021
T13 4470-4475 Body_part denotes nerve http://purl.obolibrary.org/obo/UBERON_0001021
T14 4493-4498 Body_part denotes Nerve http://purl.obolibrary.org/obo/UBERON_0001021
T15 4867-4872 Body_part denotes Elbow http://purl.obolibrary.org/obo/UBERON_0001461
T16 5016-5021 Body_part denotes Elbow http://purl.obolibrary.org/obo/UBERON_0001461
T17 5142-5147 Body_part denotes Elbow http://purl.obolibrary.org/obo/UBERON_0001461
T18 5297-5301 Body_part denotes Knee http://purl.obolibrary.org/obo/UBERON_0001465
T19 5435-5441 Body_part denotes fibula http://purl.obolibrary.org/obo/UBERON_0001446
T20 5469-5482 Body_part denotes Sensory nerve http://purl.obolibrary.org/obo/UBERON_0001027
T21 5477-5482 Body_part denotes nerve http://purl.obolibrary.org/obo/UBERON_0001021
T22 5500-5505 Body_part denotes Nerve http://purl.obolibrary.org/obo/UBERON_0001021
T23 5773-5778 Body_part denotes Elbow http://purl.obolibrary.org/obo/UBERON_0001461
T24 5920-5925 Body_part denotes Elbow http://purl.obolibrary.org/obo/UBERON_0001461
T25 6064-6069 Body_part denotes Elbow http://purl.obolibrary.org/obo/UBERON_0001461
T26 7277-7283 Body_part denotes tendon http://purl.obolibrary.org/obo/UBERON_0000043
T27 9128-9139 Body_part denotes endothelium http://purl.obolibrary.org/obo/UBERON_0001986

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T18 11-34 Disease denotes Guillain-Barré syndrome http://purl.obolibrary.org/obo/MONDO_0016218
T19 36-39 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T20 61-83 Disease denotes polyradiculoneuropathy http://purl.obolibrary.org/obo/MONDO_0006915
T21 129-138 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T22 181-184 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T23 209-218 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T24 434-437 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T25 454-462 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T26 465-474 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T27 604-612 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T28 615-624 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T29 633-636 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T30 960-968 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T31 971-980 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T32 992-995 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T33 1008-1055 Disease denotes acute inflammatory demyelinating polyneuropathy http://purl.obolibrary.org/obo/MONDO_0016218
T34 1027-1055 Disease denotes demyelinating polyneuropathy http://purl.obolibrary.org/obo/MONDO_0003334
T35 1041-1055 Disease denotes polyneuropathy http://purl.obolibrary.org/obo/MONDO_0001824
T36 1062-1103 Disease denotes Acute motor and sensory axonal neuropathy http://purl.obolibrary.org/obo/MONDO_0020348
T37 1086-1103 Disease denotes axonal neuropathy http://purl.obolibrary.org/obo/MONDO_0004183
T38 1093-1103 Disease denotes neuropathy http://purl.obolibrary.org/obo/MONDO_0005244
T39 1108-1137 Disease denotes acute motor axonal neuropathy http://purl.obolibrary.org/obo/MONDO_0020349
T40 1120-1137 Disease denotes axonal neuropathy http://purl.obolibrary.org/obo/MONDO_0004183
T41 1127-1137 Disease denotes neuropathy http://purl.obolibrary.org/obo/MONDO_0005244
T42 1243-1246 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T43 1263-1271 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T44 1274-1283 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T45 1390-1398 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T46 1401-1410 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T47 1419-1422 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T48 1653-1661 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T49 1664-1673 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T50 1682-1685 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T51 1761-1771 Disease denotes thrombosis http://purl.obolibrary.org/obo/MONDO_0000831
T52 1830-1836 Disease denotes asthma http://purl.obolibrary.org/obo/MONDO_0004979
T53 2095-2103 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T54 2124-2133 Disease denotes pneumonia http://purl.obolibrary.org/obo/MONDO_0005249
T55 2351-2357 Disease denotes asthma http://purl.obolibrary.org/obo/MONDO_0004979
T56 2457-2463 Disease denotes asthma http://purl.obolibrary.org/obo/MONDO_0004979
T57 3203-3206 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T58 3390-3396 Disease denotes ataxia http://purl.obolibrary.org/obo/MONDO_0000437
T59 3493-3509 Disease denotes collagen disease http://purl.obolibrary.org/obo/MONDO_0005554
T60 3511-3526 Disease denotes thyroid disease http://purl.obolibrary.org/obo/MONDO_0003240
T61 3853-3856 Disease denotes GA1 http://purl.obolibrary.org/obo/MONDO_0009281
T62 4007-4015 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T63 4370-4376 Disease denotes asthma http://purl.obolibrary.org/obo/MONDO_0004979
T64 4916-4919 Disease denotes ADM http://purl.obolibrary.org/obo/MONDO_0043317
T65 6254-6257 Disease denotes ADM http://purl.obolibrary.org/obo/MONDO_0043317
T66 6568-6571 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T67 6868-6878 Disease denotes vasculitis http://purl.obolibrary.org/obo/MONDO_0018882
T68 7023-7026 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T69 7533-7536 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T70 7553-7561 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T71 7564-7573 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T72 7613-7616 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T73 7772-7775 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T74 7817-7825 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T75 7828-7837 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T76 7852-7855 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T77 8051-8073 Disease denotes Miller-Fisher syndrome http://purl.obolibrary.org/obo/MONDO_0005851
T78 8101-8104 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T79 8534-8537 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T80 8592-8596 Disease denotes Zika http://purl.obolibrary.org/obo/MONDO_0018661
T81 8815-8818 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T82 8835-8843 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T83 8973-8981 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T84 8986-8989 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T85 9015-9018 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T86 9096-9104 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T87 9286-9316 Disease denotes macrophage activation syndrome http://purl.obolibrary.org/obo/MONDO_0015545
T88 9358-9361 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T89 9379-9387 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T90 9390-9399 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T91 9547-9555 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T92 9661-9664 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T93 9681-9689 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T94 9692-9701 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T95 10064-10067 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T96 10164-10167 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T97 10287-10290 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T98 10307-10315 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T99 10318-10327 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T100 10521-10524 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T101 10532-10540 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T102 10543-10552 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T103 10595-10603 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T104 10789-10812 Disease denotes Guillain-Barré syndrome http://purl.obolibrary.org/obo/MONDO_0016218
T105 11133-11156 Disease denotes Guillain-Barré syndrome http://purl.obolibrary.org/obo/MONDO_0016218
T106 11158-11161 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T107 11179-11187 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T108 11190-11199 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T109 11282-11285 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T110 11307-11328 Disease denotes peripheral neuropathy http://purl.obolibrary.org/obo/MONDO_0003620|http://purl.obolibrary.org/obo/MONDO_0005244
T112 11355-11363 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T113 11516-11519 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T114 11536-11544 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T115 11547-11556 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T5 580-581 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T6 850-855 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tests
T7 924-928 http://purl.obolibrary.org/obo/CLO_0001406 denotes 5–14
T8 1221-1222 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T9 1307-1313 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tested
T10 1792-1796 http://purl.obolibrary.org/obo/CLO_0001599 denotes A 54
T11 1817-1818 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T12 1923-1934 http://www.ebi.ac.uk/efo/EFO_0000876 denotes extremities
T13 2064-2068 http://purl.obolibrary.org/obo/UBERON_0000473 denotes test
T14 2147-2152 http://www.ebi.ac.uk/efo/EFO_0000965 denotes chest
T15 2607-2618 http://www.ebi.ac.uk/efo/EFO_0000876 denotes extremities
T16 2655-2666 http://www.ebi.ac.uk/efo/EFO_0000876 denotes extremities
T17 2727-2738 http://www.ebi.ac.uk/efo/EFO_0000876 denotes extremities
T18 2821-2843 http://purl.obolibrary.org/obo/UBERON_0001017 denotes central nervous system
T19 2821-2843 http://www.ebi.ac.uk/efo/EFO_0000302 denotes central nervous system
T20 2821-2843 http://www.ebi.ac.uk/efo/EFO_0000908 denotes central nervous system
T21 2845-2851 http://www.ebi.ac.uk/cellline#tendon denotes Tendon
T22 2845-2851 http://www.ebi.ac.uk/efo/EFO_0000952 denotes Tendon
T23 2874-2885 http://www.ebi.ac.uk/efo/EFO_0000876 denotes extremities
T24 2938-2949 http://www.ebi.ac.uk/efo/EFO_0000876 denotes extremities
T25 2996-3002 http://purl.obolibrary.org/obo/UBERON_0001630 denotes muscle
T26 2996-3002 http://purl.obolibrary.org/obo/UBERON_0005090 denotes muscle
T27 2996-3002 http://www.ebi.ac.uk/efo/EFO_0000801 denotes muscle
T28 2996-3002 http://www.ebi.ac.uk/efo/EFO_0001949 denotes muscle
T29 3052-3066 http://purl.obolibrary.org/obo/UBERON_0001630 denotes muscles of the
T30 3052-3066 http://purl.obolibrary.org/obo/UBERON_0005090 denotes muscles of the
T31 3052-3066 http://www.ebi.ac.uk/efo/EFO_0001949 denotes muscles of the
T32 3052-3059 http://www.ebi.ac.uk/efo/EFO_0000801 denotes muscles
T33 3073-3084 http://www.ebi.ac.uk/efo/EFO_0000876 denotes extremities
T34 3126-3140 http://purl.obolibrary.org/obo/UBERON_0001630 denotes muscles of the
T35 3126-3140 http://purl.obolibrary.org/obo/UBERON_0005090 denotes muscles of the
T36 3126-3140 http://www.ebi.ac.uk/efo/EFO_0001949 denotes muscles of the
T37 3126-3133 http://www.ebi.ac.uk/efo/EFO_0000801 denotes muscles
T38 3147-3158 http://www.ebi.ac.uk/efo/EFO_0000876 denotes extremities
T39 3336-3347 http://www.ebi.ac.uk/efo/EFO_0000876 denotes extremities
T40 3414-3419 http://purl.obolibrary.org/obo/UBERON_0000178 denotes Blood
T41 3414-3419 http://www.ebi.ac.uk/efo/EFO_0000296 denotes Blood
T42 3420-3425 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tests
T43 3442-3447 http://purl.obolibrary.org/obo/UBERON_0000178 denotes blood
T44 3442-3447 http://www.ebi.ac.uk/efo/EFO_0000296 denotes blood
T45 3493-3501 http://purl.obolibrary.org/obo/CHEBI_3815 denotes collagen
T46 3675-3679 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T47 3692-3697 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tests
T48 3797-3800 http://purl.obolibrary.org/obo/CLO_0003535 denotes GM2
T49 3964-3965 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T50 3996-4002 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tested
T51 4188-4194 http://purl.obolibrary.org/obo/UBERON_0001630 denotes muscle
T52 4188-4194 http://purl.obolibrary.org/obo/UBERON_0005090 denotes muscle
T53 4188-4194 http://www.ebi.ac.uk/efo/EFO_0000801 denotes muscle
T54 4188-4194 http://www.ebi.ac.uk/efo/EFO_0001949 denotes muscle
T55 4263-4269 http://purl.obolibrary.org/obo/UBERON_0001021 denotes nerves
T56 4357-4358 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T57 4414-4415 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T58 4441-4446 http://purl.obolibrary.org/obo/UBERON_0001021 denotes Nerve
T59 4470-4475 http://purl.obolibrary.org/obo/UBERON_0001021 denotes nerve
T60 4493-4498 http://purl.obolibrary.org/obo/UBERON_0001021 denotes Nerve
T61 4516-4518 http://purl.obolibrary.org/obo/CLO_0007874 denotes ms
T62 4531-4534 http://purl.obolibrary.org/obo/CLO_0007874 denotes m/s
T63 4577-4579 http://purl.obolibrary.org/obo/CLO_0007874 denotes ms
T64 4857-4859 http://purl.obolibrary.org/obo/CLO_0050507 denotes 22
T65 5477-5482 http://purl.obolibrary.org/obo/UBERON_0001021 denotes nerve
T66 5500-5505 http://purl.obolibrary.org/obo/UBERON_0001021 denotes Nerve
T67 5523-5525 http://purl.obolibrary.org/obo/CLO_0007874 denotes ms
T68 5538-5541 http://purl.obolibrary.org/obo/CLO_0007874 denotes m/s
T69 5731-5733 http://purl.obolibrary.org/obo/CLO_0053799 denotes 45
T70 5878-5880 http://purl.obolibrary.org/obo/CLO_0053799 denotes 45
T71 7243-7245 http://purl.obolibrary.org/obo/CLO_0050510 denotes 18
T72 7268-7283 http://sig.uw.edu/fma#Calcaneal_tendon denotes Achilles tendon
T73 7411-7417 http://purl.obolibrary.org/obo/UBERON_0001021 denotes nerves
T74 7941-7947 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tested
T75 8180-8186 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tested
T76 8305-8311 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tested
T77 8342-8348 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tested
T78 8423-8429 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tested
T79 8485-8490 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tests
T80 8559-8560 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T81 8597-8602 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T82 8717-8719 http://purl.obolibrary.org/obo/CLO_0050510 denotes 18
T83 8750-8754 http://purl.obolibrary.org/obo/UBERON_0000473 denotes test
T84 9077-9080 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T85 9128-9139 http://purl.obolibrary.org/obo/UBERON_0001986 denotes endothelium
T86 9189-9190 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T87 9297-9307 http://purl.obolibrary.org/obo/CLO_0001658 denotes activation
T88 9347-9348 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T89 9400-9402 http://purl.obolibrary.org/obo/CLO_0050507 denotes 22
T90 9728-9737 http://www.ebi.ac.uk/efo/EFO_0000876 denotes extremity
T91 9829-9834 http://www.ebi.ac.uk/efo/EFO_0000876 denotes limbs
T92 9863-9872 http://www.ebi.ac.uk/efo/EFO_0000876 denotes extremity
T93 10190-10194 http://purl.obolibrary.org/obo/UBERON_0000473 denotes test
T94 10336-10340 http://purl.obolibrary.org/obo/UBERON_0000473 denotes test
T95 10689-10691 http://purl.obolibrary.org/obo/CLO_0050475 denotes My
T96 10742-10745 http://purl.obolibrary.org/obo/CLO_0001302 denotes 3–4
T97 10753-10755 http://purl.obolibrary.org/obo/CLO_0050475 denotes My
T98 10768-10770 http://purl.obolibrary.org/obo/CLO_0007653 denotes me
T99 10939-10941 http://purl.obolibrary.org/obo/CLO_0050475 denotes my
T100 11204-11208 http://purl.obolibrary.org/obo/UBERON_0000473 denotes test

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T1 247-258 Chemical denotes glycolipids http://purl.obolibrary.org/obo/CHEBI_33563
T2 267-278 Chemical denotes ganglioside http://purl.obolibrary.org/obo/CHEBI_28892
T3 884-887 Chemical denotes GM1 http://purl.obolibrary.org/obo/CHEBI_18216|http://purl.obolibrary.org/obo/CHEBI_61048|http://purl.obolibrary.org/obo/CHEBI_73110
T6 894-898 Chemical denotes GQ1b http://purl.obolibrary.org/obo/CHEBI_27515
T7 908-912 Chemical denotes GD1b http://purl.obolibrary.org/obo/CHEBI_28175
T8 1712-1714 Chemical denotes IV http://purl.obolibrary.org/obo/CHEBI_74327
T9 1715-1720 Chemical denotes gamma http://purl.obolibrary.org/obo/CHEBI_30212
T10 2154-2160 Chemical denotes oxygen http://purl.obolibrary.org/obo/CHEBI_25805
T11 2246-2256 Chemical denotes budesonide http://purl.obolibrary.org/obo/CHEBI_3207
T12 2258-2277 Chemical denotes formoterol fumarate http://purl.obolibrary.org/obo/CHEBI_31633
T13 2258-2268 Chemical denotes formoterol http://purl.obolibrary.org/obo/CHEBI_5147
T14 2269-2277 Chemical denotes fumarate http://purl.obolibrary.org/obo/CHEBI_29806
T15 2278-2285 Chemical denotes hydrate http://purl.obolibrary.org/obo/CHEBI_35505
T16 2290-2308 Chemical denotes montelukast sodium http://purl.obolibrary.org/obo/CHEBI_6993
T17 2290-2301 Chemical denotes montelukast http://purl.obolibrary.org/obo/CHEBI_50730
T18 2302-2308 Chemical denotes sodium http://purl.obolibrary.org/obo/CHEBI_26708
T19 2380-2393 Chemical denotes betamethasone http://purl.obolibrary.org/obo/CHEBI_3077
T20 3448-3455 Chemical denotes glucose http://purl.obolibrary.org/obo/CHEBI_17234|http://purl.obolibrary.org/obo/CHEBI_4167
T22 3530-3537 Chemical denotes vitamin http://purl.obolibrary.org/obo/CHEBI_33229
T23 3656-3663 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T24 3748-3759 Chemical denotes ganglioside http://purl.obolibrary.org/obo/CHEBI_28892
T25 3760-3768 Chemical denotes antigens http://purl.obolibrary.org/obo/CHEBI_59132
T26 3792-3795 Chemical denotes GM1 http://purl.obolibrary.org/obo/CHEBI_18216|http://purl.obolibrary.org/obo/CHEBI_61048|http://purl.obolibrary.org/obo/CHEBI_73110
T29 3797-3800 Chemical denotes GM2 http://purl.obolibrary.org/obo/CHEBI_141420|http://purl.obolibrary.org/obo/CHEBI_51013|http://purl.obolibrary.org/obo/CHEBI_60327|http://purl.obolibrary.org/obo/CHEBI_89635
T33 3802-3806 Chemical denotes GD1a http://purl.obolibrary.org/obo/CHEBI_18163|http://purl.obolibrary.org/obo/CHEBI_82607
T35 3808-3812 Chemical denotes GD1b http://purl.obolibrary.org/obo/CHEBI_28175
T36 3814-3817 Chemical denotes GD3 http://purl.obolibrary.org/obo/CHEBI_28424|http://purl.obolibrary.org/obo/CHEBI_89636
T38 3819-3830 Chemical denotes GalNAc-GD1a http://purl.obolibrary.org/obo/CHEBI_59228
T39 3819-3825 Chemical denotes GalNAc http://purl.obolibrary.org/obo/CHEBI_28037|http://purl.obolibrary.org/obo/CHEBI_28800
T41 3826-3830 Chemical denotes GD1a http://purl.obolibrary.org/obo/CHEBI_18163|http://purl.obolibrary.org/obo/CHEBI_82607
T43 3832-3836 Chemical denotes GT1a http://purl.obolibrary.org/obo/CHEBI_27691
T44 3838-3842 Chemical denotes GT1b http://purl.obolibrary.org/obo/CHEBI_28058
T45 3844-3848 Chemical denotes GQ1b http://purl.obolibrary.org/obo/CHEBI_27515
T46 3853-3856 Chemical denotes GA1 http://purl.obolibrary.org/obo/CHEBI_27717|http://purl.obolibrary.org/obo/CHEBI_27938
T48 3865-3868 Chemical denotes GM1 http://purl.obolibrary.org/obo/CHEBI_18216|http://purl.obolibrary.org/obo/CHEBI_61048|http://purl.obolibrary.org/obo/CHEBI_73110
T51 3871-3882 Chemical denotes Ganglioside http://purl.obolibrary.org/obo/CHEBI_28892
T52 3924-3932 Chemical denotes antigens http://purl.obolibrary.org/obo/CHEBI_59132
T53 4521-4529 Chemical denotes Velocity http://purl.obolibrary.org/obo/CHEBI_145500
T54 5355-5358 Chemical denotes EDB http://purl.obolibrary.org/obo/CHEBI_28534
T55 5528-5536 Chemical denotes Velocity http://purl.obolibrary.org/obo/CHEBI_145500
T56 6361-6364 Chemical denotes EDB http://purl.obolibrary.org/obo/CHEBI_28534
T57 6947-6953 Chemical denotes metals http://purl.obolibrary.org/obo/CHEBI_33521
T58 6964-6970 Chemical denotes toxins http://purl.obolibrary.org/obo/CHEBI_27026
T59 7056-7058 Chemical denotes IV http://purl.obolibrary.org/obo/CHEBI_74327
T60 7957-7968 Chemical denotes ganglioside http://purl.obolibrary.org/obo/CHEBI_28892
T61 8157-8168 Chemical denotes ganglioside http://purl.obolibrary.org/obo/CHEBI_28892
T62 8363-8366 Chemical denotes GM1 http://purl.obolibrary.org/obo/CHEBI_18216|http://purl.obolibrary.org/obo/CHEBI_61048|http://purl.obolibrary.org/obo/CHEBI_73110
T65 8373-8377 Chemical denotes GQ1b http://purl.obolibrary.org/obo/CHEBI_27515
T66 8387-8391 Chemical denotes GD1b http://purl.obolibrary.org/obo/CHEBI_28175
T67 10831-10836 Chemical denotes gamma http://purl.obolibrary.org/obo/CHEBI_30212

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
45 1295-1302 Species denotes patient Tax:9606
46 1741-1749 Species denotes patients Tax:9606
47 267-278 Chemical denotes ganglioside MESH:D005732
48 884-887 Chemical denotes GM1 MESH:D005677
49 61-83 Disease denotes polyradiculoneuropathy MESH:D011129
50 129-138 Disease denotes infection MESH:D007239
51 209-218 Disease denotes infection MESH:D007239
52 454-474 Disease denotes SARS-CoV-2 infection MESH:C000657245
53 604-624 Disease denotes SARS-CoV-2-infection MESH:C000657245
54 960-980 Disease denotes SARS-CoV-2-infection MESH:C000657245
55 1027-1055 Disease denotes demyelinating polyneuropathy MESH:D003711
56 1078-1103 Disease denotes sensory axonal neuropathy MESH:C536450
57 1108-1137 Disease denotes acute motor axonal neuropathy MESH:D000208
58 1263-1283 Disease denotes SARS-CoV-2 infection MESH:C000657245
59 1390-1410 Disease denotes SARS-CoV-2-infection MESH:C000657245
60 1653-1673 Disease denotes SARS-CoV-2-infection MESH:C000657245
61 1761-1771 Disease denotes thrombosis MESH:D013927
89 3098-3114 Gene denotes proximal and 4/4
90 3024-3040 Gene denotes proximal and 5/5
91 3379-3382 Gene denotes she Gene:126669
92 3160-3163 Gene denotes she Gene:126669
93 2690-2693 Gene denotes she Gene:126669
94 2561-2564 Gene denotes she Gene:126669
95 2116-2119 Gene denotes she Gene:126669
96 1993-1996 Gene denotes she Gene:126669
97 1806-1811 Species denotes woman Tax:9606
98 2095-2105 Species denotes SARS-CoV-2 Tax:2697049
99 2154-2160 Chemical denotes oxygen MESH:D010100
100 2246-2256 Chemical denotes budesonide MESH:D019819
101 2258-2285 Chemical denotes formoterol fumarate hydrate MESH:D000068759
102 2290-2308 Chemical denotes montelukast sodium MESH:C093875
103 2380-2393 Chemical denotes betamethasone MESH:D001623
104 1830-1836 Disease denotes asthma MESH:D001249
105 1894-1902 Disease denotes numbness MESH:D006987
106 1907-1915 Disease denotes weakness MESH:D018908
107 1970-1991 Disease denotes neurological symptoms MESH:D009422
108 2007-2012 Disease denotes cough MESH:D003371
109 2017-2022 Disease denotes fever MESH:D005334
110 2124-2133 Disease denotes pneumonia MESH:D011014
111 2351-2357 Disease denotes asthma MESH:D001249
112 2457-2463 Disease denotes asthma MESH:D001249
113 2585-2593 Disease denotes numbness MESH:D006987
114 2711-2719 Disease denotes weakness MESH:D018908
115 3390-3396 Disease denotes ataxia MESH:D001259
127 3814-3817 Gene denotes GD3 Gene:117189
128 4007-4017 Species denotes SARS-CoV-2 Tax:2697049
129 4041-4048 Species denotes patient Tax:9606
130 4345-4352 Species denotes patient Tax:9606
131 3448-3455 Chemical denotes glucose MESH:D005947
132 3748-3759 Chemical denotes ganglioside MESH:D005732
133 3871-3882 Chemical denotes Ganglioside MESH:D005732
134 3493-3509 Disease denotes collagen disease MESH:D003095
135 3511-3526 Disease denotes thyroid disease MESH:D013959
136 3530-3551 Disease denotes vitamin abnormalities MESH:D014802
137 4370-4376 Disease denotes asthma MESH:D001249
139 6085-6097 Species denotes L  Malleolus Tax:273487
142 6283-6286 Gene denotes APB Gene:6051
143 6430-6445 Disease denotes flexor hallucis MESH:D052582
148 6710-6713 Gene denotes She Gene:126669
149 6893-6896 Gene denotes she Gene:126669
150 6868-6878 Disease denotes vasculitis MESH:D014657
151 6904-6914 Disease denotes malignancy MESH:D009369
154 7028-7031 Gene denotes she Gene:126669
155 6996-7003 Species denotes patient Tax:9606
160 7455-7458 Gene denotes she Gene:126669
161 7212-7215 Gene denotes she Gene:126669
162 7432-7440 Disease denotes weakness MESH:D018908
163 7483-7491 Disease denotes numbness MESH:D006987
167 7553-7573 Disease denotes SARS-CoV-2 infection MESH:C000657245
168 7780-7806 Disease denotes neurological complications MESH:D002493
169 7817-7837 Disease denotes SARS-CoV-2 infection MESH:C000657245
191 7897-7905 Species denotes patients Tax:9606
192 8024-8032 Species denotes patients Tax:9606
193 8313-8321 Species denotes patients Tax:9606
194 8592-8602 Species denotes Zika virus Tax:64320
195 8615-8623 Species denotes patients Tax:9606
196 8835-8845 Species denotes SARS-CoV-2 Tax:2697049
197 8959-8967 Species denotes patients Tax:9606
198 9096-9106 Species denotes SARS-CoV-2 Tax:2697049
199 9365-9373 Species denotes patients Tax:9606
200 9533-9541 Species denotes patients Tax:9606
201 7957-7968 Chemical denotes ganglioside MESH:D005732
202 8157-8168 Chemical denotes ganglioside MESH:D005732
203 8363-8366 Chemical denotes GM1 MESH:D005677
204 8935-8955 Disease denotes respiratory symptoms MESH:D012818
205 8973-8981 Disease denotes COVID-19 MESH:C000657245
206 9154-9164 Disease denotes axonopathy MESH:D016472
207 9191-9213 Disease denotes microvascular disorder MESH:D017566
208 9379-9399 Disease denotes SARS-CoV-2 infection MESH:C000657245
209 9445-9466 Disease denotes neurological symptoms MESH:D009422
210 9509-9529 Disease denotes respiratory symptoms MESH:D012818
211 9547-9555 Disease denotes COVID-19 MESH:C000657245
223 9813-9820 Species denotes patient Tax:9606
224 9968-9976 Species denotes patients Tax:9606
225 10111-10118 Species denotes patient Tax:9606
226 9681-9701 Disease denotes SARS-CoV-2 infection MESH:C000657245
227 9728-9746 Disease denotes extremity weakness MESH:D018908
228 9751-9763 Disease denotes paraesthesia MESH:D010292
229 9778-9799 Disease denotes neurological symptoms MESH:D009422
230 9836-9852 Disease denotes Axonal disorders MESH:D012183
231 9863-9890 Disease denotes extremity dominant symptoms MESH:D051271
232 9943-9955 Disease denotes neuropathies MESH:D009422
233 9982-9997 Disease denotes microangiopathy MESH:D000783
237 10273-10281 Species denotes patients Tax:9606
238 10307-10327 Disease denotes SARS-CoV-2 infection MESH:C000657245
239 10532-10552 Disease denotes SARS-CoV-2 infection MESH:C000657245
241 10554-10561 Species denotes Patient Tax:9606
248 10582-10589 Disease denotes anxious MESH:D001007
249 10595-10603 Disease denotes COVID-19 MESH:C000657245
250 10626-10647 Disease denotes neurological symptoms MESH:D009422
251 10656-10677 Disease denotes numbness and weakness MESH:D006987
252 11004-11012 Disease denotes weakness MESH:D018908
253 11039-11047 Disease denotes numbness MESH:D006987
256 11119-11127 Species denotes Patients Tax:9606
257 11179-11199 Disease denotes SARS-CoV-2 infection MESH:C000657245
262 11332-11340 Species denotes patients Tax:9606
263 11355-11365 Species denotes SARS-CoV-2 Tax:2697049
264 11307-11328 Disease denotes peripheral neuropathy MESH:D010523
265 11341-11349 Disease denotes infected MESH:D007239
267 11536-11556 Disease denotes SARS-CoV-2 infection MESH:C000657245

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T2 1027-1040 Phenotype denotes demyelinating http://purl.obolibrary.org/obo/HP_0011096
T3 1041-1055 Phenotype denotes polyneuropathy http://purl.obolibrary.org/obo/HP_0001271
T4 1078-1103 Phenotype denotes sensory axonal neuropathy http://purl.obolibrary.org/obo/HP_0003390
T5 1114-1137 Phenotype denotes motor axonal neuropathy http://purl.obolibrary.org/obo/HP_0007002
T6 1830-1836 Phenotype denotes asthma http://purl.obolibrary.org/obo/HP_0002099
T7 2007-2012 Phenotype denotes cough http://purl.obolibrary.org/obo/HP_0012735
T8 2017-2022 Phenotype denotes fever http://purl.obolibrary.org/obo/HP_0001945
T9 2124-2133 Phenotype denotes pneumonia http://purl.obolibrary.org/obo/HP_0002090
T10 2351-2357 Phenotype denotes asthma http://purl.obolibrary.org/obo/HP_0002099
T11 2457-2463 Phenotype denotes asthma http://purl.obolibrary.org/obo/HP_0002099
T12 2800-2843 Phenotype denotes abnormalities in the central nervous system http://purl.obolibrary.org/obo/HP_0002011
T13 3390-3396 Phenotype denotes ataxia http://purl.obolibrary.org/obo/HP_0001251
T14 3511-3526 Phenotype denotes thyroid disease http://purl.obolibrary.org/obo/HP_0000820
T15 4370-4376 Phenotype denotes asthma http://purl.obolibrary.org/obo/HP_0002099
T16 6804-6831 Phenotype denotes elevated sedimentation rate http://purl.obolibrary.org/obo/HP_0003565
T17 6868-6878 Phenotype denotes vasculitis http://purl.obolibrary.org/obo/HP_0002633
T18 7268-7283 Phenotype denotes Achilles tendon http://purl.obolibrary.org/obo/HP_0025273
T19 9323-9337 Phenotype denotes cytokine storm http://purl.obolibrary.org/obo/HP_0033041
T20 9722-9746 Phenotype denotes lower extremity weakness http://purl.obolibrary.org/obo/HP_0007340
T21 11307-11328 Phenotype denotes peripheral neuropathy http://purl.obolibrary.org/obo/HP_0009830
T22 11393-11414 Phenotype denotes autoimmune conditions http://purl.obolibrary.org/obo/HP_0002960

LitCovid-PD-GO-BP

Id Subject Object Predicate Lexical cue
T1 2046-2059 http://purl.obolibrary.org/obo/GO_0003968 denotes transcriptase
T2 2046-2059 http://purl.obolibrary.org/obo/GO_0003899 denotes transcriptase
T3 4195-4211 http://purl.obolibrary.org/obo/GO_0001508 denotes action potential
T4 7284-7290 http://purl.obolibrary.org/obo/GO_0060004 denotes reflex
T5 9286-9307 http://purl.obolibrary.org/obo/GO_0042116 denotes macrophage activation
T6 11103-11111 http://purl.obolibrary.org/obo/GO_0007612 denotes Learning

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T10 0-10 Sentence denotes BACKGROUND
T11 11-155 Sentence denotes Guillain-Barré syndrome (GBS) is an acute type of polyradiculoneuropathy, that occurs following immune events such as infection and vaccination.
T12 156-325 Sentence denotes Approximately 40%–70% of GBS cases develop following infection, and autoantibodies against glycolipids (mainly ganglioside antibodies) are detected in over 50% of cases.
T13 326-488 Sentence denotes The cause is generally accepted to be an abnormality in the immune process.1 2 Recently, several reports of GBS associated with SARS-CoV-2 infection have emerged.
T14 489-1061 Sentence denotes However, as far as we have investigated, there are still no reports in Japan.3 However, in a review of 37 cases of SARS-CoV-2-infection-related GBS, less than half of the studies investigated antiganglioside antibodies.4 Furthermore, few reports have provided details related to the antiganglioside antibody investigated, and clear descriptions of the relevant tests are available only for anti-GM1, anti-GQ1b and anti-GD1b antibodies.5–14 Most reported cases (64.8%) of SARS-CoV-2-infection-associated GBS were of the acute inflammatory demyelinating polyneuropathy type.
T15 1062-1353 Sentence denotes Acute motor and sensory axonal neuropathy and acute motor axonal neuropathy types were observed in 13.5% and 2.7% of cases.4 In the present report, we discuss a case of axonal-type GBS associated with SARS-CoV-2 infection, where the patient was tested for various antiganglioside antibodies.
T16 1354-1554 Sentence denotes Furthermore, we review the cases of SARS-CoV-2-infection-related GBS reported to date, in order to provide insight into the clinical characteristics and pathological mechanisms underlying the disease.
T17 1555-1772 Sentence denotes Our report also highlights the need for clinicians to remain cautious when attempting to diagnose SARS-CoV-2-infection-related GBS, and when using high-dose IV gamma globulin therapy in patients at risk of thrombosis.
T18 1774-1791 Sentence denotes Case presentation
T19 1792-1935 Sentence denotes A 54-year-old woman with a history of asthma was admitted to our hospital in May 2020 with reports of numbness and weakness in her extremities.
T20 1936-2106 Sentence denotes Twenty days prior to the onset of neurological symptoms, she developed cough and fever; oropharyngeal reverse transcriptase PCR test results were positive for SARS-CoV-2.
T21 2107-2176 Sentence denotes Although she had pneumonia on CT of the chest, oxygen was not needed.
T22 2177-2358 Sentence denotes Therefore, we did not administer additional treatment, and continued budesonide, formoterol fumarate hydrate and montelukast sodium, that were originally being used to treat asthma.
T23 2359-2464 Sentence denotes In addition, we used betamethasone only for the first 2 days to avoid the risk of exacerbation of asthma.
T24 2465-2537 Sentence denotes Following approximately 2 weeks of treatment, PCR results were negative.
T25 2538-2667 Sentence denotes However, at that time, she began to experience numbness in the lower extremities, that gradually spread to the upper extremities.
T26 2668-2739 Sentence denotes Within the next week, she began to develop weakness in the extremities.
T27 2740-2844 Sentence denotes Neurological examination revealed no findings suggestive of abnormalities in the central nervous system.
T28 2845-2950 Sentence denotes Tendon reflexes in the upper extremities were normal, although they were absent in the lower extremities.
T29 2951-3181 Sentence denotes The Medical Research Council Scale grade for muscle strength was 4/4 for proximal and 5/5 for distal muscles of the lower extremities, and 4/4 for proximal and 4/4 for distal muscles of the upper extremities; she was able to walk.
T30 3182-3279 Sentence denotes Her modified Erasmus GBS Outcome Score (mEGOS) was 3/9, while her Hughes’ functional grade was 2.
T31 3280-3397 Sentence denotes Superficial sensation was mildly impaired in the distal extremities, deep sensation was normal and she had no ataxia.
T32 3399-3413 Sentence denotes Investigations
T33 3414-3552 Sentence denotes Blood tests revealed normal blood glucose levels and no findings suggestive of collagen disease, thyroid disease or vitamin abnormalities.
T34 3553-3687 Sentence denotes Cerebrospinal fluid (CSF) assessment at admission at approximately 3 weeks after onset revealed normal protein levels and cell counts.
T35 3688-3743 Sentence denotes All tests for antiganglioside antibodies were negative.
T36 3744-3870 Sentence denotes The ganglioside antigens used in the ELISA were GM1, GM2, GD1a, GD1b, GD3, GalNAc-GD1a, GT1a, GT1b, GQ1b and GA1 (asialo-GM1).
T37 3871-4022 Sentence denotes Ganglioside complexes containing two of the above 10 antigens were also used as described in a previous study.15 CSF was not tested for SARS-CoV-2 PCR.
T38 4023-4101 Sentence denotes On admission, the patient’s first electrophysiological examination was normal.
T39 4102-4334 Sentence denotes However, the second examination performed 1 week later revealed decreases in compound muscle action potential (CMAP) amplitudes in the median, radial and tibial nerves compared with those obtained in the first examination (table 1).
T40 4335-4431 Sentence denotes Since the patient had a history of asthma, we did not perform lumbar MRI using a contrast agent.
T41 4432-4463 Sentence denotes Table 1 Nerve conduction study
T42 4464-4492 Sentence denotes Motor nerve conduction study
T43 4493-4580 Sentence denotes Nerve Distal latency (ms) Velocity (m/s) Amplitude (mV) F-wave minimal latency (ms)
T44 4581-4751 Sentence denotes At admission 1 week later 1 month later At admission 1 week later 1 month later At admission 1 week later 1 month later At admission 1 week later 1 month later
T45 4752-4760 Sentence denotes Median L
T46 4761-4865 Sentence denotes  Wrist–APB 3.4 (N<4.0) 3.7 3.4 57.7(N>50) 55.6 57.7 10.8 (N>7) 7.8 10.9 24.0 (N<29) 22 22.8
T47 4866-4900 Sentence denotes  Elbow–wrist 9.6 7.5 10.2
T48 4901-4908 Sentence denotes Ulnar L
T49 4909-5014 Sentence denotes  Wrist–ADM 2.6 (N<3.4) 2.6 2.8 58.8 (N>50) 56.4 60.8 10.0 (N>7) 11.1 8.2 21.1 (N<30) 24 23.2
T50 5015-5050 Sentence denotes  Elbow–wrist 9.4 10.7 7.7
T51 5051-5059 Sentence denotes Radial L
T52 5060-5140 Sentence denotes  Wrist–EIP 2.6 (N<2.9) 2.4 2.4 56.9 (N>50) 55.6 61.4 7.2 (N>7) 5.0 5.7
T53 5141-5175 Sentence denotes  Elbow–wrist 6.1 4.5 5.2
T54 5176-5184 Sentence denotes Tibial L
T55 5185-5295 Sentence denotes  Malleolus–FHB 3.6 (N<6.0) 3.8 3.2 50.8 (N>40) 46.5 46.9 22.6 (N>5) 16.3 20.3 42.8 (N<50) 46 44.1
T56 5296-5336 Sentence denotes  Knee–malleolus 18.6 13.9 15.7
T57 5337-5347 Sentence denotes Peroneal L
T58 5348-5427 Sentence denotes  Ankle–EDB 3.9 (N<5.5) 4.4 3.7 46.4 (N>40) 45.4 47.2 6.6 (N>5) 6.4 8.2
T59 5428-5468 Sentence denotes  Below fibula–ankle 6.2 5.7 7.0
T60 5469-5499 Sentence denotes Sensory nerve conduction study
T61 5500-5558 Sentence denotes Nerve Distal latency (ms) Velocity (m/s) Amplitude (mV)
T62 5559-5686 Sentence denotes At admission 1 week later 1 month later At admission 1 week later 1 month later At admission 1 week later 1 month later
T63 5687-5695 Sentence denotes Median L
T64 5696-5771 Sentence denotes  Wrist 3.1 (N<4.0) 3 3 48.4 (N>45) 49.0 48.7 24.1 (N>10) 22.9 19.1
T65 5772-5830 Sentence denotes  Elbow–wrist 60.1 (N>50) 56.1 61.1 12.1 12.5 10.8
T66 5831-5838 Sentence denotes Ulnar L
T67 5839-5918 Sentence denotes  Wrist 2.1 (N<3.4) 2.2 2.2 53.7 (N>45) 56.3 53.6 16.9 (N>10) 17.2 18.9
T68 5919-5974 Sentence denotes  Elbow–wrist 66.3 (N>50) 61.0 64.6 5.9 6.3 6.1
T69 5975-5983 Sentence denotes Radial L
T70 5984-6062 Sentence denotes  Wrist 2.5 (N<2.9) 1.8 2.1 58.5 (N>50) 56.8 59.1 19.1 (N>7) 21.3 18.2
T71 6063-6075 Sentence denotes  Elbow–wrist
T72 6076-6086 Sentence denotes Peroneal L
T73 6087-6166 Sentence denotes  Malleolus 2.7 (N<6.0) 2.7 3.4 51.9 (N>40) 52.2 47.3 3.2 (N>5) 7.3 3.2
T74 6167-6174 Sentence denotes Sural L
T75 6175-6253 Sentence denotes  Ankle 2.1 (N<5.5) 2.8 2.2 46.7 (N>40) 49.6 47.7 10.4 (N>5) 11.9 13.7
T76 6254-6473 Sentence denotes ADM, abductor digiti minimi; APB, abductor pollicis brevis; Bold, at least 20% lower than the first value; EDB, extensor digitorum brevis; EIP, extensor indicis proprius; FHB, flexor hallucis brevis; L, left; N, normal.
T77 6475-6497 Sentence denotes Differential diagnosis
T78 6498-6709 Sentence denotes This case fulfilled two of the required features for the diagnosis of GBS based on the criteria described by Asbury and Cornblath.16 In addition, several other clinical features strongly supported the diagnosis.
T79 6710-6879 Sentence denotes She had no systemic symptoms, multiorgan involvement or elevation of serological markers (eg, elevated sedimentation rate or rheumatoid factor) suggestive of vasculitis.
T80 6880-6971 Sentence denotes Furthermore, she had no malignancy or history of exposure to heavy metals and other toxins.
T81 6973-6982 Sentence denotes Treatment
T82 6983-7120 Sentence denotes Although the patient was diagnosed with GBS, she was followed up without IV immunoglobulin therapy due to her mEGOS and functional grade.
T83 7122-7143 Sentence denotes Outcome and follow-up
T84 7144-7309 Sentence denotes Approximately 2 weeks later, her symptoms had begun to improve, and she was discharged home on day 18; normalisation of the Achilles tendon reflex was also observed.
T85 7310-7418 Sentence denotes An electrophysiological examination performed 1 month later revealed improved CMAP amplitude in most nerves.
T86 7419-7492 Sentence denotes Although her weakness had improved, she continued to experience numbness.
T87 7494-7504 Sentence denotes Discussion
T88 7505-7883 Sentence denotes Although the possibility of GBS associated with SARS-CoV-2 infection remains to be clarified, the number of GBS cases reported between March 2020 and April 2020 is greater than five times that reported in the last 3 years.17 Given that reports have begun to describe GBS and neurological complications following SARS-CoV-2 infection, the onset of GBS requires special attention.
T89 7884-8006 Sentence denotes Among the 37 patients described by Caress et al, 17 were tested for anti-ganglioside antibodies, 15 of whom were negative.
T90 8007-8105 Sentence denotes In addition, two patients were positive for Miller-Fisher syndrome, and all were negative for GBS.
T91 8106-8219 Sentence denotes However, specific description of types of the anti-ganglioside antibodies tested were not provided in many cases.
T92 8220-8533 Sentence denotes Although some reports specifically described the types of antiganglioside antibodies tested, patients appear to have been tested only for anti-GM1, anti-GQ1b and anti-GD1b antibodies.9 10 14 Although we tested for various additional antiganglioside antibodies, all tests were negative in the present case as well.
T93 8534-8846 Sentence denotes GBS was also reported in a case–control study of the 2016 Zika virus, where most patients were negative for antiganglioside antibodies, suggesting the existence of unknown antibodies.18 Therefore, it is important to test for as many kinds of antibodies as possible when suspecting GBS associated with SARS-CoV-2.
T94 8847-9058 Sentence denotes However, some authors have reported nearly simultaneous development of neurological and respiratory symptoms in patients with COVID-19 and GBS.19 20 Thus, the cause of GBS may not be immune related in all cases.
T95 9059-9214 Sentence denotes Previous research has suggested that SARS-CoV-2 damages the vascular endothelium.21 Therefore, axonopathy may have been caused by a microvascular disorder.
T96 9215-9629 Sentence denotes In addition, McGonagle et al proposed that hyperinflammation following macrophage activation syndrome (ie, ‘cytokine storm’) may be a cause of GBS in patients with SARS-CoV-2 infection.22 Together, these findings suggest that, if neurological symptoms develop early following the appearance of respiratory symptoms in patients with COVID-19, both autoimmune and other factors should be considered in the diagnosis.
T97 9630-9835 Sentence denotes Whittaker et al noted that the GBS associated with SARS-CoV-2 infection manifests mainly as lower extremity weakness and paraesthesia.23 Similarly, neurological symptoms began in our patient’s lower limbs.
T98 9836-9998 Sentence denotes Axonal disorders and lower extremity dominant symptoms may be similar in character to the length-dependent neuropathies observed in patients with microangiopathy.
T99 9999-10168 Sentence denotes The present case satisfied the essential diagnostic criteria for GBS described by Asbury and Cornblath, and the patient’s clinical course supported the diagnosis of GBS.
T100 10169-10221 Sentence denotes Nonetheless, the CSF test yielded atypical findings.
T101 10222-10381 Sentence denotes In conclusion, our report supports the notion that patients with GBS associated with SARS-CoV-2 infection tend to test negative for antiganglioside antibodies.
T102 10382-10553 Sentence denotes In addition to careful diagnosis, further reports are required to elucidate the characteristics and the mechanisms underlying the onset of GBS due to SARS-CoV-2 infection.
T103 10554-10575 Sentence denotes Patient’s perspective
T104 10576-10688 Sentence denotes I was anxious when COVID-19 symptoms improved and neurological symptoms such as numbness and weakness developed.
T105 10689-10752 Sentence denotes My symptoms gradually progressed and peaked in about 3–4 weeks.
T106 10753-10813 Sentence denotes My doctor told me that I might have Guillain-Barré syndrome.
T107 10814-10951 Sentence denotes I was told about gamma globulin treatment, but I declined that option due to the risk of side effects and the mild nature of my symptoms.
T108 10952-11057 Sentence denotes After that, the symptoms gradually improved and the weakness disappeared, although the numbness remained.
T109 11058-11102 Sentence denotes I was satisfied with the treatment protocol.
T110 11103-11118 Sentence denotes Learning points
T111 11119-11260 Sentence denotes Patients with Guillain-Barré syndrome (GBS) associated with SARS-CoV-2 infection may test negative for many known antiganglioside antibodies.
T112 11261-11415 Sentence denotes Careful diagnosis of GBS is required, because peripheral neuropathy in patients infected with SARS-CoV-2 may have causes other than autoimmune conditions.
T113 11416-11557 Sentence denotes Further studies and case reports are required to facilitate discussion of the mechanisms underlying GBS associated with SARS-CoV-2 infection.

LitCovid-PD-GlycoEpitope

Id Subject Object Predicate Lexical cue glyco_epitope_db_id
T1 879-887 GlycoEpitope denotes anti-GM1 http://www.glycoepitope.jp/epitopes/AN0713
T2 884-887 GlycoEpitope denotes GM1 http://www.glycoepitope.jp/epitopes/EP0050
T3 894-898 GlycoEpitope denotes GQ1b http://www.glycoepitope.jp/epitopes/EP0069
T4 903-912 GlycoEpitope denotes anti-GD1b http://www.glycoepitope.jp/epitopes/AN0403
T5 908-912 GlycoEpitope denotes GD1b http://www.glycoepitope.jp/epitopes/EP0059
T6 3792-3795 GlycoEpitope denotes GM1 http://www.glycoepitope.jp/epitopes/EP0050
T7 3802-3806 GlycoEpitope denotes GD1a http://www.glycoepitope.jp/epitopes/EP0056
T8 3808-3812 GlycoEpitope denotes GD1b http://www.glycoepitope.jp/epitopes/EP0059
T9 3819-3830 GlycoEpitope denotes GalNAc-GD1a http://www.glycoepitope.jp/epitopes/EP0058
T10 3826-3830 GlycoEpitope denotes GD1a http://www.glycoepitope.jp/epitopes/EP0056
T11 3832-3836 GlycoEpitope denotes GT1a http://www.glycoepitope.jp/epitopes/EP0066
T12 3838-3842 GlycoEpitope denotes GT1b http://www.glycoepitope.jp/epitopes/EP0067
T13 3844-3848 GlycoEpitope denotes GQ1b http://www.glycoepitope.jp/epitopes/EP0069
T14 3865-3868 GlycoEpitope denotes GM1 http://www.glycoepitope.jp/epitopes/EP0050
T15 8358-8366 GlycoEpitope denotes anti-GM1 http://www.glycoepitope.jp/epitopes/AN0713
T16 8363-8366 GlycoEpitope denotes GM1 http://www.glycoepitope.jp/epitopes/EP0050
T17 8373-8377 GlycoEpitope denotes GQ1b http://www.glycoepitope.jp/epitopes/EP0069
T18 8382-8391 GlycoEpitope denotes anti-GD1b http://www.glycoepitope.jp/epitopes/AN0403
T19 8387-8391 GlycoEpitope denotes GD1b http://www.glycoepitope.jp/epitopes/EP0059